Difference between revisions of "Anakinra (Kineret)"
Jump to navigation
Jump to search
m |
m |
||
| Line 1: | Line 1: | ||
Recombinant IL-1 receptor antagonist | Recombinant IL-1 receptor antagonist | ||
| − | ==Diseases for which it is | + | ==Diseases for which it is used== |
*[[Castleman disease]] | *[[Castleman disease]] | ||
Revision as of 18:09, 6 November 2023
Recombinant IL-1 receptor antagonist
Diseases for which it is used
Also known as
- Brand name: Kineret